Skip to main content
. 2017 Jun 29;27:43. doi: 10.1038/s41533-017-0040-z

Fig. 1.

Fig. 1

Number of patients by therapy combination at COPD diagnosis (overall cohort). COPD chronic obstructive pulmonary disease, ICS inhaled corticosteroids, LABA long-acting beta-agonists, LAMA long-acting muscarinic antagonists, SABA short-acting beta-agonists, SAMA short-acting muscarinic antagonists